- Home
- BZUN vs CRVO Comparison
BZUN vs CRVO Comparison
Compare BZUN & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BZUN | CRVO |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.4M | 78.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BZUN | CRVO |
|---|---|---|
| Price | $2.70 | $7.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.50 |
| AVG Volume (30 Days) | ★ 169.9K | 52.8K |
| Earning Date | 11-25-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,372,022,139.00 | $6,159,786.00 |
| Revenue This Year | $6.28 | N/A |
| Revenue Next Year | $4.10 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.08 | N/A |
| 52 Week Low | $2.12 | $1.92 |
| 52 Week High | $4.88 | $16.94 |
Technical Indicators
Market Signals| Indicator | BZUN | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 38.30 | 43.60 |
| Support Level | $2.68 | $7.29 |
| Resistance Level | $2.77 | $8.55 |
| Average True Range (ATR) | 0.10 | 0.51 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 24.42 | 31.73 |
Price Performance
Historical ComparisonAbout BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.